Insulitis in human type 1 diabetes: A comparison between patients and animal models

Seminars in Immunopathology

Volumn 36, Issue 5, 2014, Pages 569-579

  In’t Veld, Peter ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

Author keywords

Autoimmunity; Insulin; Insulitis; Islets of Langerhans; Pancreas; Type 1 diabetes

Indexed keywords

ANIMAL; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DISEASE MODEL; HUMAN; IMMUNOLOGY; INFLAMMATION; MOUSE; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PATHOLOGY;

ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD;

EID: 84930791607     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-014-0438-4     Document Type: Review

References (90)

1. Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes. Lancet 383:69–82
2. Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. New Eng J Med 314:1360–1368
3. Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and beta cell loss in type 1 diabetes. Nat Rev 5:219–226
4. Herold KC, Vignali DAA, Cooke A, Bluestone JA (2013) Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nat Rev 13:243–256
5. Van Belle TL, Coppieters KT, von Herrath MG (2011) Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 91:79–118
6. In’t Veld P, Marichal M (2010) Microscopic anatomy of the human islet of langerhans. The islets of Langerhans. Adv Exp Med Biol 654:1–19
7. Itoh N, Hanafusa T, Miyazaki A, Miyagawa J, Yamagata K, Yamamoto K, Waguri M, Imagawa A, Tamura S, Inada M, Kawata S, Tarui S, Kono N, Matsuzawa Y (1993) Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 92:2313–2322
8. Imagawa A, Hanafusa T, Tamura S, Moriwaki M, Itoh N, Yamamoto K, Iwahashi H, Yamagat K, Waguri M, Nanmo T, Uno S, Nakajima H, Namba M, Kawata S, Miyagawa J, Matsuzawa Y (2001) Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes. Close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes 50:1269–1273
9. In’t Veld P (2011) Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets 3:1–8
10. Leiter EH, von Herrath M (2004) Animal models have little to teach us about type 1 diabetes: 2. In opposition of this proposal. Diabetologia 47:1657–1660
11. Roep BO, Atkinson M (2004) Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal. Diabetologia 47:1650–1656
12. Roep BO, Atkinson M, von Herrath M (2004) Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nat Rev 4:989–997
13. Staeva TP, Chatenoud L, Insel R, Atkinson MA (2013) Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials. Diabetes 62:9–17
14. Chatenoud L, Thervet E, Primo J, Bach JF (1994) Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci U S A 91:123–127
15. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De Block C, Seigneurin JM, De Pauw P, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach JF, Pipeleers D, Chatenoud L (2005) Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 23:2598–2608
16. Campbell-Thompson M, Wasserfall C, Kaddis J, Albanese-O’Neill A, Staeva T, Nierras C, Moraski J, Rowe P, Gianani R, Eisenbarth G, Crawford J, Schatz D, Pugliese A, Atkinson M (2012) Network for pancreatic organ donors with diabetes (nPOD): developing a tissue biobank for type 1 diabetes. Diabetes Metab Res Rev 28:608–617
17. Schmidt MB (1902) Ueber die beziehung der langenhans’schen inseln des pankreas zum diabetes mellitus. Münch Med Wochenschr 49:51–54
18. Von Meyenburg M (1940) Ueber “Insulitis” bei diabetes. Schweiz Med Wochenschr 21:554–557
19. Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633
20. LeCompte PM (1958) “Insulitis” in early juvenile diabetes. Arch Pathol Lab Med 66:450–457
21. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2008) Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 155:173–181
22. Gale EAM (2001) The discovery of type 1 diabetes. Diabetes 50:217–226
23. Gepts W, De Mey J (1978) Islet cell survival determined by morphology: an immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27(Suppl 1):251–261
24. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS (1986) The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267–274
25. Ahmad N, Abraham AA (1982) Pancreatic isleitis with coxsackie virus B5 infection. Hum Pathol 13:661–662
26. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. New Engl J Med 313:353–360
27. Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC (2007) Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of ketoacidosis. Diabetologia 50:2323–2331
28. Cecil RL (1909) A study of the pathological anatomy of the pancreas in ninety cases of diabetes mellitus. J Exp Med 11:266–289
29. Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TWH, Atkinson MA, Roep BO, von Herrath MG (2013) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 209:51–60
30. Crome L (1967) Fulminating diabetes with lymphocytic thyroiditis. Arch Dis Child 42:677–681
31. Dotta F, Censini S, van Halteren AGS, Marseli L, Masini M, Dionisi S, Mosca F, Boggi U, Onetti Muda A, Del Prato S, Elliott JF, Covacci A, Rappuoli R, Roep BO, Marchetti P (2007) Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 104:5115–5120
32. Foulis AK, Farquharson MA, Hardman R (1987) Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:333–343
33. Gianani R, Campbell-Thompson M, Sarkar SA, Wasserfall C, Pugliese A, Solis JM, Kent SC, Hering BJ, West E, Steck A, Bonner-Weir S, Atkinson MA, Coppieters K, von Herrath M, Eisenbarth GS (2010) Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia 53:690–698
34. Gladisch R, Bayer HP, Lipinski C, Stenzel M (1975) Insulitis und perakuter diabetes mellitus. Z Kinderheilk 119:5–14
35. Hänninen A, Jalkanen S, Samli M, Toikkanen S, Nikolarakos G, Simell O (1992) Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 90:1901–1910
36. Heiberg KA (1911) Ueber diabetes bei kindern. Arch Kinderheilkunde 56:403–411
37. In’t Veld P, Lievens D, De Grijse J, Ling Z, Van der Auwera B, Pipeleers-Marichal M, Gorus F, Pipeleers D (2007) Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56:2400–2404
38. Junker K, Egeberg J, Kromann H, Nerup J (1977) An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus. Acta Pathol Microbiol Scand Sect A 85:699–706
39. Kent SC, Chen Y, Bregoli L, Clemmings SM, Kenyon NS, Ricordi C, Hering BJ, Hafler DA (2005) Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435:224–228
40. Klöppel G, Drenck CR, Oberholzer M (1984) Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes. Virchows Arch 403:441–452
41. Lecompte PM, Legg MA (1972) Insulitis (lymphocytic infiltration of pancreatic islets) in late-onset diabetes. Diabetes 21:762–769
42. Lernmark A, Klöppel G, Stenger D, Vathanaprida C, Fält K, Landin-Olsson M, Baskin DG, Palmer JP, Gown AM, Petersen JS, Li L, Edenvall H, Mauseth RS (1995) Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus. Virchows Arch 425:631–640
43. Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC (2006) Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49:1838–1844
44. Nagler W (1963) Diabetic coma with acute inflammation of islets of Langerhans. J Am Med Assoc 184:723–724
45. Nakanishi KT, Miyashita H, Okubo M, Sugimoto T, Murase T, Kosaka K, Hara M (1993) Relationship among residual beta cells, exocrine pancreas and islet cell antibodies in insulin-dependent diabetes mellitus. Metabolism 42:196–203
46. Planas R, Carillo J, Sanchez A, Ruiz de Villa MC, Nunez F, Verdaguer J, James RFL, Pujol-Borrell R, Vives-Pi M (2009) Gene expression profiles for the human pancreas and purified islets in type 1 diabetes: new findings at clinical onset and in long-standing diabetes. Clin Exp Immunol 159:23–44
47. Shimada A, Imazu Y, Morinaga S, Funae O, Kasuga A, Atsumi Y, Matsuoka K (1999) T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. Diabetes Care 22:615–717
48. Somoza N, Vargas F, Roura-Mir C, Vives-Pi M, Fernandez-Figuereas MT, Ariza A, Gomis R, Bragado R, Marti M, Jaraquemada D, Pujol-Borrell R (1994) Pancreas in recent-onset insulin-dependent diabetes mellitus: changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor Vbeta usage, and cytokine profile. J Immunol 153:1360–1377
49. Stansfield OH, Warren S (1928) Inflammation involving the islands of Langerhans in diabetes; a report on pathological findings. New Eng J Med 198:686–687
50. Uno S, Imagawa A, Okita K, Sayama K, Moriwaki M, Iwahashi H, Yamagata K, Tamura S, Matsuzawa Y, Hanafusa T, Miyagawa J, Shimomura I (2007) Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor alpha in patients with recent-onset type 1 diabetes. Diabetologia 50:596–601
51. Warne GL (1973) Foetal cerebral oedema with insulitis in diabetic ketoacidosis. Med J Aust 2:934–937
52. Warren S (1927) The pathology of diabetes in children. J Am Med Assoc 88:99–101
53. Yoon JW, Austin M, Onodera T, Notkins AL (1979) Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300:1173–1179
54. Foulis AK, Stewart JA (1984) The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine tissue. Diabetologia 26:456–461
55. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS (1996) Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bcd/IA-2 autoantibodies. Diabetes 45:926–933
56. Gorus FK, Keymeulen B, In’t Veld PA, Pipeleers DG (2013) Predictors of progression to type 1 diabetes: preparing for immune interventions in the preclinical disease phase. Expert Rev Clin Immunol 9:1173–1183
57. Gianani R, Putnam A, Still T, Yu L, Miao D, Gill RG, Beilke J, Supon P, Valentine A, Iveson A, Dunn S, Eisenbarth GS, Hutton J, Gottlieb P, Wiseman A (2006) Initial results of screening of non-diabetic organ donors for expression of islet autoantigens. J Clin Endocrinol Metab 91:1855–1861
58. Oikarinen M, Tauriainen S, Honkanen T, Vuori K, Karhunen P, Vasama-Nolvi C, Oikarinen S, Verbeke C, Blair GE, Rantala I, Ilonen J, Simell O, Knip M, Hyöty (2008) Analysis of pancreatic tissue in a child positive for islet cell antibodies. Diabetologia 51:1796–1802
59. Wagner R, McNally JM, Bonifacio E, Genovese S, Foulis A, McGill M, Christie MR, Betterle C, Bosi E, Botazzo GF (1994) Lack of immunohistologic changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies. Diabetes 43:851–56
60. Doniach I, Morgan AG (1973) Islets of Langerhans in juvenile diabetes mellitus. Clin Endocrinol 2:233–248
61. Warren S, Root HF (1925) The pathology of diabetes, with special reference to pancreatic regeneration. Am J Pathol 1:415–429
62. Pipeleers D, Ling Z (1992) Pancreatic beta cells in insulin-dependent diabetes. Diabetes Metab Rev 8:209–227
63. Campbell-Thompson ML, Atkinson MA, Butler AE, Chapman NM, Frisk G, Gianani R, Giepmans BN, von Herrath MG, Hyöty H, Kay TW, Korsgren O, Morgan NG, Powers AC, Pugliese A, Richardson SJ, Rowe PR, Tracy S, In’t Veld PA (2013) The diagnosis of insulitis in human type 1 diabetes. Diabetologia 56:2541–2543
64. Dabelea D, Mayer-Davis EJ, Andrews JS, Dolan LM, Pihoker C, Hamman RF, Greenbaum C, Marcovina S, Fujimoto W, Linder B, Imperatore G, D’Agostino R (2012) Clinical evolution of beta cell function in youth with diabetes: the SEARCH for diabetes in youth study. Diabetologia 55:3359–3368
65. Greenbaum CJ, Beam CA, Boulware D, Gitelman SE, Gottlieb PA, Herold KC, Lachin JM, McGee P, Palmer JP, Pescovitz MD, Krause-Steinrauf H, Skyler JS, Sosenko JM (2012) Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite type 1 diabetes TrialNet data. Diabetes 61:2066–2073
66. Rahier J, Goebbels RM, Henquin JC (1983) Cellular composition of the human diabetic pancreas. Diabetologia 24:366–371
67. Stefan Y, Orci L, Malaisse-Lagae F, Perrelet A, Patel Y, Unger RH (1982) Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 31:694–700
68. Löhr M, Klöppel G (1987) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757–762
69. Keenan HA, Sun JK, Levine J, Doria A, Aiello LP, Eisenbarth G, Bonner-Weir S, King GL (2010) Residual insulin production and pancreatic beta cell turnover after 50 years of diabetes: Joslin Medalist study. Diabetes 59:2846–2853
70. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration. Diabetologia 48:2221–2228
71. Anderson MS and Bluestone JA (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 447–485
72. Leiter EH (1977) The NOD mouse: a model for insulin-dependent diabetes mellitus. In: Current protocols in immunology, unit 15.9. Wiley, New York
73. Leiter EH (1993) The NOD mouse: a model for analyzing the interplay between heredity and environment in development of autoimmune disease. ILAR news 35:4–14
74. Driver JP, Serreze DV, Chen YG (2011) Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. Semin Immunopathol 33:67–87
75. Carrero JA, Calderon B, Towfic F, Artyomov MN, Unanue ER (2013) Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse. PLoS ONE 8:e59701
76. Janssen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA (1994) Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta cell destruction in NOD mice. Diabetes 43:667–675
77. Alanentalo T, Hörnblad A, Mayans S, Nilsson AK, Sharpe J, Larefalk A, Ahlgren U, Holmberg D (2010) Quantification and three-dimensional imaging of the insulitis-induced destruction of beta cells in murine type 1 diabetes. Diabetes 59:1756–1764
78. Quah HS, Miranda-Hernandez S, Khoo A, Harding A, Fynch S, Elkerbout L, Brodnicki TC, Baxter AG, Kay TWH, Thomas HE, Graham KL (2013) Deficiency in type I interferon signaling prevents the early inteferon-gene signature in pancreatic islets but not type 1 diabetes in non-obese diabetic mice. Diabetes (in press)
79. Aloisi F, Pujol-Borrell R (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 6:205–215
80. Hjelmstrom P, Fjell J, Nakagawa T, Sacca R, Cuff CA, Ruddle NH (2000) Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am J Pathol 156:1133–1138
81. Penaranda C, Tang Q, Ruddle NH, Bluestone JA (2010) Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs. Diabetes 50:1461–1468
82. Sreenan S, Pick AJ, Levisetti M, Baldwin AC, Pugh W, Polonsky KS (1999) Increased beta cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes 48:989–996
83. Sherry NA, Kushner JA, Glandt M, Kitamura T, Brillantes AB, Herold KC (2006) Effects of autoimmunity and immune therapy on beta cell turnover in type 1 diabetes. Diabetes 55:3238–3244
84. Dirice E, Kahraman S, Jiang W, El Ouaamari A, De Jesus DF, Teo AKK, Hu J, Kawamori D, Gaglia JL, Mathis D, Kulkarni RN (2014) Soluble factors secreted by T cells promote beta cell proliferation. Diabetes 63:188–202
85. Fujita T, Yui R, Kusumoto Y, Serizawa Y, Makini S, Tochino Y (1982) Lymphocytic insulitis in a ‘non-obese diabetic (NOD)’ strain of mice: an immunohistochemical and electron microscope investigation. Biomed Res 3:429–443
86. In’t Veld PA, De Munck N, van Belle K, Buelens N, Ling Z, Haentjens P, Gorus F, Pipeleers-Marichal M, Pipeleers D (2010) Beta cell replication is increased in donor organs from young patients after prolonged life support. Diabetes 59:1702–1708
87. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2010) Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes. Diabetologia 53:2020–2028
88. Skog O, Korsgren S, Melhus A, Korsgren O (2013) Revisiting the notion of type 1 diabetes being a T-cell mediated autoimmune disease. Curr Opin Endocrinol Diab Obes 20:118–123
89. Korsgren O, Molin Y, Salmela K, Lundgren T, Melhus A, Korsgren O (2012) On the etiology of type 1 diabetes: a new animal model signifying a decisive role for bacteria eliciting an adverse innate immunity response. Am J Pathol 181:1735–1748
90. In’t Veld P (2011) Insulitis in the human endocrine pancreas: does a viral infection lead to inflammation and beta cell replication? Diabetologia 54:2220–2222